Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Citi sets Rocket Lab Buy rating with $6 stock price target

Published 02/12/2024, 04:22 AM
Updated 02/12/2024, 04:27 AM
© Reuters.

On Monday, Citi reinstated coverage on Rocket Lab USA (NASDAQ:RKLB), issuing a Buy rating and establishing a price target of $6.00. The move follows recent financial activities and a significant contract awarded to the aerospace manufacturer by the U.S. government.

Citi's reinstatement comes after Rocket Lab's recent capital market transactions, which are believed to provide the necessary liquidity for the company to fulfill its existing orders, develop new products, and potentially engage in strategic mergers and acquisitions. The firm also noted the U.S. government's award as a sign of increasing customer adoption of Rocket Lab's offerings.

The analyst at Citi explained that the $6 price target is based on a transaction multiple of 3.6 times, applied to their 2026 revenue forecast for Rocket Lab. This valuation reflects the analyst's positive outlook on the company's financial prospects and market position.

Rocket Lab, known for its advancements in space technology and launch services, has been focusing on expanding its capabilities and market share. The company's recent financial maneuvers and the government contract are seen as steps toward solidifying its presence in the industry.

InvestingPro Insights

As Citi reinstates coverage on Rocket Lab USA (NASDAQ:RKLB) with a Buy rating and a price target of $6.00, it's important to consider several key financial metrics and analyst insights. Rocket Lab's market capitalization currently stands at roughly $2.11 billion, reflecting the investor confidence in its future prospects. Despite this, the company's P/E ratio remains negative at -12.3 for the last twelve months as of Q3 2023, indicating that it has not been profitable during this period.

InvestingPro Tips suggest that Rocket Lab holds more cash than debt on its balance sheet, which is a positive sign of financial health and could be a contributing factor to Citi's optimistic outlook. Additionally, the company's liquid assets are reported to exceed its short-term obligations, providing further evidence of a solid financial foundation. On the other hand, analysts do not anticipate Rocket Lab will be profitable this year, which is consistent with the negative P/E ratio observed.

From a growth perspective, Rocket Lab's revenue has seen a 26.59% increase over the last twelve months as of Q3 2023. However, it's worth noting that the stock has experienced a significant decline over the last six months, with a 31.33% drop in its price total return. This could indicate a disconnect between the company's operational growth and its stock market performance, which investors should consider when evaluating the potential for future recovery and growth.

For readers interested in a deeper dive into Rocket Lab's financials and future outlook, there are more InvestingPro Tips available at https://www.investing.com/pro/RKLB. Use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and gain access to valuable insights that could inform your investment decisions. There are a total of 8 additional InvestingPro Tips for Rocket Lab, offering a comprehensive analysis of the company's financial health and market potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.